The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2024Powered Clothing and Wearable Robotics for Everyday Gait Support
Study Rationale: We’ve spent several years exploring the potential of supporting human movement with wearable robotics and we believe our work has tremendous potential for individuals with Parkinson’s...
-
Research Grant, 2023Chronos-PD: Using Proteomic Analysis to Detect Early Molecular Signatures of Parkinson’s Disease
Study Rationale: Parkinson’s disease (PD) is a gradually progressive condition: by the time the disorder is recognized and diagnosed, it is often too late to protect or reverse the damage that has...
-
Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2023Analysis of Skin Biopsies from the Systemic Synuclein Sampling Study by Alpha-synuclein Seed Amplification Assay
Study Rationale: Alpha-synuclein seed amplification assays have been shown to enable an accurate and early diagnosis of Parkinson’s disease (PD). However, this test currently relies on cerebrospinal...
-
Research Grant, 2023Assessment of the Novel Neuronal Synuclein Disease Staging System in Stratifying Dementia with Lewy Bodies Patients
Study Rationale: Dementia with Lewy bodies (DLB) is a common form of dementia that carries a more serious outlook than others, such as Alzheimer's disease (AD). Similar to Parkinson's disease (PD)...
-
Research Grant, 2024Discovery of PET Tracers for Measuring Alpha-synuclein
Study Rationale: The discovery of new treatments for Parkinson’s disease (PD) has been slowed by the amount of time (years) it takes to determine whether a drug was effective in a clinical trial. New...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2024Assessment of IRL757 for the Treatment of Apathy in Parkinson's Disease
Study Rationale: People with Parkinson’s disease (PD) frequently develop a loss of motivation and initiative. Such apathy can be burdensome for patients and their families and caregivers and is...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.